Dr. Bhatti is a healthcare executive with a proven track record of driving innovation and value creation at the intersection of healthcare and technology. Prior to founding digitalXhealth, Dr. Bhatti served as CEO of Cumulus Neuroscience, a UK-based digital biomarker company advancing the development of precision CNS medicines. Dr. Bhatti led the company to being named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2024 after securing FDA-clearance of the 3x award-winning Cumulus at-home EEG headset in the previous year.
Prior to Cumulus, Dr. Bhatti founded AliveCor BioPharma, a division of AliveCor, a leading Silicon Valley based startup developing cutting edge cardiovascular solutions. Dr. Bhatti has over a decade of senior experience within the consumer healthcare industry, having previously served as the Global Head of Digital Medicines at Sanofi Consumer Health where he led digital transformation initiatives globally to improve patient outcomes with companies like Google, Facebook, and Plug&Play. His previous roles also include leading medical teams at Reckitt, Novartis, and GSK (now Haleon) launching, innovating, and globally expanding market presence of several major OTC brands including Mucinex, Flonase, Otrivin, and Nicorette.
Dr. Bhatti’s passion is to bring to life innovative digital solutions to improve health access and equity within underserved communities which has been fueled by his rich history of working within leading consumer healthcare companies. Dr. Bhatti also serves as a strategic advisor to multiple digital health startups allowing him to stay up-to-date on the latest trends and innovations in healthcare.